J 2023

Preparticipation Screening of Athletes: The Prevalence of Positive Family History

BOGNA, Jiravska Godula, Otakar JIRAVSKÝ, Petra PESOVA, Libor JELINEK, Marketa SOVOVA et. al.

Základní údaje

Originální název

Preparticipation Screening of Athletes: The Prevalence of Positive Family History

Autoři

BOGNA, Jiravska Godula (203 Česká republika), Otakar JIRAVSKÝ (203 Česká republika, garant, domácí), Petra PESOVA (203 Česká republika), Libor JELINEK (203 Česká republika), Marketa SOVOVA (203 Česká republika), Katarina MORAVCOVA (203 Česká republika), Jaromir OZANA (203 Česká republika), Miroslav HUDEC (203 Česká republika, domácí), Roman MIKLÍK (203 Česká republika, domácí), Jan HECKO (203 Česká republika), Libor SKNOURIL (203 Česká republika) a Eliska SOVOVA (203 Česká republika)

Vydání

JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE, Basel, MDPI, 2023, 2308-3425

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30201 Cardiac and Cardiovascular systems

Stát vydavatele

Švýcarsko

Utajení

není předmětem státního či obchodního tajemství

Odkazy

Impakt faktor

Impact factor: 2.400 v roce 2022

Kód RIV

RIV/00216224:14110/23:00133336

Organizační jednotka

Lékařská fakulta

UT WoS

000977794700001

Klíčová slova anglicky

sudden cardiac death; athlete; preparticipation screening

Štítky

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 31. 1. 2024 09:39, Mgr. Tereza Miškechová

Anotace

V originále

Sudden cardiac death (SCD) is a leading cause of death among athletes, and those with a positive family history (FH) of SCD and/or cardiovascular disease (CVD) may be at increased risk. The primary objective of this study was to assess the prevalence and predictors of positive FH of SCD and CVD in athletes using four widely used preparticipation screening (PPS) systems. The secondary objective was to compare the functionality of the screening systems. In a cohort of 13,876 athletes, 1.28% had a positive FH in at least one PPS system. Multivariate logistic regression analysis identified the maximum heart rate as significantly associated with positive FH (OR = 1.042, 95% CI = 1.027-1.056, p < 0.001). The highest prevalence of positive FH was found using the PPE-4 system (1.20%), followed by FIFA, AHA, and IOC systems (1.11%, 0.89%, and 0.71%, respectively). In conclusion, the prevalence of positive FH for SCD and CVD in Czech athletes was found to be 1.28%. Furthermore, positive FH was associated with a higher maximum heart rate at the peak of the exercise test. The findings of this study revealed significant differences in detection rates between PPS protocols, so further research is needed to determine the optimal method of FH collection.